In AML, overexpression or mutations of DNMT1, DNMT3A, and DNMT3B frequently result in aberrant methylation patterns, leading to dysregulation of key genes that drive leukemogenesis [153]. Here, DNMT3A is linked to acute myeloid leukemia.